European Journal of Integrative Medicine
Volume 1, Issue 1 , Pages 19-25, April 2009

Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology

  • Oliver Micke

      Affiliations

    • Department of Radiotherapy and Radiation Oncology, Franziskus Hospital, Bielefeld, Germany
    • Corresponding Author InformationCorresponding author at: Klinik für Strahlentherapie und Radioonkologie, Franziskus Hospital, Kiskerstraße 26, D-33615 Bielefeld, Germany. Tel.: +495215891801; fax: +495215891804.
  • ,
  • Frank Bruns

      Affiliations

    • Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany
  • ,
  • Michael Glatzel

      Affiliations

    • Department of Radiotherapy, Suhl Central Hospital, Suhl, Germany
  • ,
  • Klaus Schönekaes

      Affiliations

    • Radiotherapy Practice, Minden, Germany
  • ,
  • Patrick Micke

      Affiliations

    • Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
  • ,
  • Ralph Mücke

      Affiliations

    • Department of Radiotherapy, St. Josef Hospital, Wiesbaden, Germany
  • ,
  • Jens Büntzel

      Affiliations

    • Department of Otolaryngology, Südharz Hospital, Nordhausen, Germany

Received 5 January 2009; received in revised form 27 January 2009; accepted 9 February 2009. published online 08 August 2011.

Abstract 

Introduction

A multi-center study was performed to identify factors predicting the use of complementary and alternative medicine (CAM) in radiotherapy patients, giving patients the information and the support they request.

Methodology

A total of 1013 consecutive patients receiving radiotherapy for malignant diseases were interviewed using a structured questionnaire. Multivariate logistic stepwise backward regression was used to analyze the replies.

Results

A total of 59% of patients reported using CAM therapies. CAM use was more common in female patients, generally higher in advanced stages, and most common in breast cancer, followed by Hodgkin's disease, other gynecologic malignancies, renal cell carcinoma, rectal cancer, and prostate cancer. The most frequently reported CAM therapies were vitamins, mistletoe, selenium, and other trace elements. Multivariate logistic stepwise backward regression showed that age, gender, tumor type and stage, and smoking behavior were significant predictors of CAM use. The highest relative risk (RR) was calculated for breast cancer patients, while the lowest RR was calculated for head and neck cancer patients.

Discussion

This study represents the largest analysis of CAM use among radiotherapy cancer patients. More than half of the patients undergoing radiotherapy for cancer were using CAM. In general, the typical CAM user was a female patient suffering from breast cancer, a non-smoker and non-drinker, had an advanced stage of disease, and was treated with curative intentions.

Keywords: Complementary and alternative medicine (CAM), Predictive factors, Radiation oncology, Unconventional cancer treatments

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1876-3820(09)00005-5

doi:10.1016/j.eujim.2009.02.001

European Journal of Integrative Medicine
Volume 1, Issue 1 , Pages 19-25, April 2009